| May 1998 | ReqMed was founded by Kyowa Hakko Kogyo Co., Ltd. and Tadashi Matsumoto to facilitate pharmaceutical companies in creating strategic alliances with innovative bio-pharmaceutical companies |
| Jun 1999 | ReqMed became independent from Kyowa Hakko Kogyo Co., Ltd. |
| Feb 2000 | Life Science Venture Fund (LSVF I) , an investment fund specializing in the biotechnology field that was the first of its kind in Japan, was created |
| Nov 2000 | ReqMed Research, Inc. was founded in South San Francisco to facilitate partnerships between US and Japanese firms |
| Nov 2001 | ReqMed raised 150 million yen through its first Private equity financing |
| Aug 2003 | ReqMed raised 200 million yen for our collaborative "Drug Development Project" through its second Private equity financing |
| Sep 2003 | ReqMed Venture Capital (RMVC) was established to separate the investment business from the consulting business |
| Feb 2004 | Life Science Venture Fund II (LSVF II) was founded by RMVC and mblVC |
| Apr 2004 | ReqMed announced a strategic alliance with CMIC Co., Ltd., the largest CRO in Japan |
| Feb 2006 | ReqMed raised 707 million yen for our collaborative "Drug Development Project" through its third private equity fancing |
| Jan 2007 | Phase I study of NaPPS(pentosan) commenced by owned sponsorship |
| Jun 2008 | License Agreement with Asahi Kasei Pharma Corporation in partnership with bene pharmaChem GmbH & Co.KG for the development of NaPPS in Japan |
History
TOP